News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ESMO 2023: Cemiplimab neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma
Regeneron Pharmaceuticals, Inc. today announced the first presentation of key secondary endpoints for an investigational…